Jeffrey N Myers

24PUBLICATIONS
194CO-AUTHORS
Cancer diagnosisMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMicroelectromechanical systems (MEMS)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jul 14, 2026
IL-1α Expands SLC2A1highSPP1highIFNlow Myeloid Cells to Drive Immune Escape and Malignant Transformation of Pre-cancers.

|Dec 28, 2025
BATF2 is a glutamine-responsive tumour suppressor required for type-I interferon-dependent anti-tumour immunity.

Wang Gong, Hülya F Taner, Yuesong Wu

|Nov 18, 2025
Chemotherapy alone for stage II-IVa laryngeal squamous cell carcinoma: A 20-year follow-up.

Mateus Trinconi Cunha, Matheus Sewastjanow-Silva, F Christopher Holsinger

|Oct 06, 2025
Bypassing cisplatin resistance in Nrf2 hyperactivated head and neck cancer through effective PI3Kinase targeting.

Pedram Yadollahi, Kelli A McCord, Yang Li

|Aug 20, 2025
Cancer-induced nerve injury promotes resistance to anti-PD-1 therapy.

Erez N Baruch, Frederico O Gleber-Netto, Priyadharsini Nagarajan

|Jul 31, 2025
Nrf2 Hyperactivation as a Driver of Radiotherapy Resistance and Suppressed Antitumor Immunity in Head and Neck Squamous Cell Carcinoma.

Rutulkumar Patel, Kalil Saab, Lixia Luo

Pageof 4

Frequent Collaborators

5 joint publications

Frederico O Gleber-Netto

5 joint publications

Jing Wang

5 joint publications

Mitchell J Frederick

4 joint publications

Renata Ferrarotto